Telix Pharmaceuticals axes $25 million share purchase plan
MELBOURNE: Billion-dollar cancer imaging biotech Telix Pharmaceuticals has cancelled the $25 million share purchase plan
MELBOURNE: Billion-dollar cancer imaging biotech Telix Pharmaceuticals has cancelled the $25 million share purchase plan
FEATURED
Seniors housing operators must embrace healthcare-based models
Investor survey and trends report into seniors living & care published
Elderly sisters and laypeople share housing and community in béguinage
Retirement villages excoriated in brutal media take down by critics
Build-to-rent continues take off in one city
Seniors to be targeted by new housing provider
INNOVATION
